Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Konrad, R. J.
space
  arrow  Davis, W. L.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Tumor Necrosis Factor and Coxsackie B4 Rhabdomyolysis

right arrow Robert J. Konrad; David B. P. Goodman; and Walter L. Davis

15 October 1993 | Volume 119 Issue 8 | Pages 861-862


TO THE EDITOR:

A 23-year-old man presented with sore throat, diffuse muscle pain and weakness, enlarged tonsils, cervical lymphadenopathy, and myoglobinuria. His leukocyte count was 14.6 x 109/L; his lactate dehydrogenase concentration was 8200 U/L; his aspartate aminotransferase level was 2601 U/L; and his creatine kinase concentration was 650 000 U/L. Only twice previously have higher creatine kinase elevations been reported in virus-associated rhabdomyolysis [1, 2].


View this table:
[in this window]
[in a new window]
 
Table 1. Superoxide Release after 2 Hours Incubation Assayed by Spectrophotometric Measurement*

 
The patient was hydrated vigorously and was given indomethacin for pain relief; his creatine kinase concentration was 46 000 U/L at discharge 5 days after admission. Despite the severity of the rhabdomyolysis, the patient recovered completely, and his serum enzyme levels returned to normal 3 weeks later.

Antibody titers to the following viruses were examined: influenza viruses A and B; Coxsackie viruses B1, B2, B3, B4, B5, and B6; echovirus (types 4, 9, 11, and 30); and adenovirus. Convalescent-phase serum showed an eightfold increase in antibody titer to Coxsackie B4 virus compared with acute-phase serum (titer, 1:128 compared with 1:16).

As shown in Table 1, skeletal muscle breakdown, measured by superoxide release in a well-characterized animal model—Solenopsis species (red imported fire ant) [3, 4]—was increased by the patient's acute-phase serum (100 µL) or the cytokine tumor necrosis factor-{alpha} (TNF-{alpha}) (minimum amount, 40 pg/mL). No TNF-{alpha} was detectable in convalescent-phase and control sera (Cistron TNF-{alpha} enzyme-linked immunosorbent assay). The patient's acute-phase serum contained 22 ± 3 pg/mL TNF-{alpha}.

In our patient, acute-phase serum contained an elevated level of TNF-{alpha} and induced skeletal muscle breakdown and increased superoxide production in vitro in a fashion similar to that caused by TNF-{alpha}. As with TNF-{alpha}, this myolysis was specifically blocked by anti-TNF-{alpha} antibody.


References
space
up arrowTop
dotReferences

1. Tanaka T, Takada T, Takagi D, Takeyama N, Kitazawa Y. Acute renal failure due to rhabdomyolysis associated with Echovirus 9 infection: a case report and review of literature. Jpn J Med. 1989; 28:237-42.

2. Fukuyama Y, Ando T, Yokata J. Acute fulminant myoglobinuric polymyositis with picornavirus-like crystals. J Neurol Neurosurg Psychiatr. 1977; 40:775-7.

3. Davis WL, Jones RG, Farmer GR. Insect hemolymph factor promotes histolysis in Solenopsis. Anat Record. 1989; 224:473-8.

4. Babior BR, Kipnes ZR, Curnutte J. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bacteriocidal agent. J Clin Invest. 1973; 52:741-9.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Konrad, R. J.
space
  arrow  Davis, W. L.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online